HOME > ARCHIVE
ARCHIVE
- Chugai: Sales Up 6.7% Due to Good Performance of Mainstays
June 10, 2002
- Kuraya Sanseido: Sales, Profits Sharply Up Due to Cost Cutting
June 10, 2002
- Time Is Running Out for Passage of Healthcare Reform Bills
June 10, 2002
- Dainippon: Sales, Profits Up 3 Years in a Row
June 10, 2002
- Suzuken: Consolidated Sales Up to \955.7 Bil.
June 10, 2002
- Revised Forecasts of Social Security Benefits Released
June 10, 2002
- Takeda: Becomes 1st Japanese Drug House with Sales of Over \1 Trillion
June 10, 2002
- Azwell: Operating Profits Return to Black
June 10, 2002
- Model Curriculum for Pharmacists Drafted by PSJ
June 10, 2002
- Sankyo: Overseas Sales Make Up for Japan's Weak Sales, but Profits Down
June 10, 2002
- Fukujin: Sales Up 9.5% to \455 Bil.
June 10, 2002
- Olympus: Strong Overseas Sales of Medical Endoscopes Support Growth
June 10, 2002
- Tanabe: Sales Decline Due to Transfer of Diagnostics to Eiken
June 10, 2002
- Toho Pharm: Profits Down Despite 16.8% Increase in Sales
June 10, 2002
- Cost Calculation Method Employed for Elastase, Acetylcysteine
June 10, 2002
- Ono: Opalmon, Onon Drive Sales, Profits
June 10, 2002
- Vital-Net: Becomes No. 1 Drug Wholesaler in Tohoku Region
June 10, 2002
- OTC NEWS IN BRIEF
June 10, 2002
- Tsumura: Net Profits for 1st Time in 5 Years
June 10, 2002
- BULLETIN
June 10, 2002
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
